Catheter Precision Inc. (NYSE:VTAK) shares are trending on Wednesday.
Shares of the Carolina-based medical device and technology company jumped 26.62% to $0.90 in after-hours trading on Tuesday, after Catheter Precision announced Flyte, its regional air mobility unit, will equip its Cirrus Vision Jet fleet with LifeVac‘s airway-clearance devices.
Why It Matters for Investors
LifeVac developed the first Food and Drug Administration-authorized non-powered device designed to help clear a blocked airway during choking emergencies. The device has been used in thousands of reported choking incidents around the world. It is used by families, schools, healthcare facilities, first responders and other organizations that want to be better prepared for choking emergencies.
According to the company, the LifeVac deal extends the fleet’s safety systems from flight-deck technology into cabin medical preparedness, reinforcing Flyte’s standardized, single-aircraft-type strategy.
